140 related articles for article (PubMed ID: 15665795)
1. Drug-eluting stents: clinical perspectives on drug and design differences.
Rogers CD
Rev Cardiovasc Med; 2005; 6 Suppl 1():S3-12. PubMed ID: 15665795
[TBL] [Abstract][Full Text] [Related]
2. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
3. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
Perin EC
Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
[TBL] [Abstract][Full Text] [Related]
4. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of drug-eluting stents.
Williams DO; Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794
[TBL] [Abstract][Full Text] [Related]
7. The approach to small vessels in the era of drug-eluting stents.
Holmes DR; Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S31-7. PubMed ID: 15665796
[TBL] [Abstract][Full Text] [Related]
8. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
[TBL] [Abstract][Full Text] [Related]
9. The present and future of drug-eluting stents.
Indolfi C; Mongiardo A; Spaccarotella C; Ferraro A; Torella D
Ital Heart J; 2005 Jun; 6(6):498-506. PubMed ID: 16008155
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
11. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
Iijima R; Mehilli J; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
[TBL] [Abstract][Full Text] [Related]
12. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
13. The role of BMS in the drug eluting stent era: is still there any place for them?
Fineschi M; Gori T
Catheter Cardiovasc Interv; 2006 Sep; 68(3):456; author reply 457. PubMed ID: 16892446
[No Abstract] [Full Text] [Related]
14. Drug-eluting stents: a multidisciplinary success story.
Burt HM; Hunter WL
Adv Drug Deliv Rev; 2006 Jun; 58(3):350-7. PubMed ID: 16546288
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
Ryan J; Cohen DJ; Pinto DS
Coron Artery Dis; 2006 Dec; 17(8):667-71. PubMed ID: 17119374
[TBL] [Abstract][Full Text] [Related]
16. Overstretching undersized drug-eluting stents: a temporary solution.
Bass TA
Catheter Cardiovasc Interv; 2004 Apr; 61(4):461-2. PubMed ID: 15065138
[No Abstract] [Full Text] [Related]
17. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
18. Xience V everolimus-eluting coronary stent.
Kukreja N; Onuma Y; Serruys PW
Expert Rev Med Devices; 2009 May; 6(3):219-29. PubMed ID: 19419279
[TBL] [Abstract][Full Text] [Related]
19. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease.
Kornowski R; Vaknin-Assa H; Assali A; Fuchs S
Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
Aziz S; Ramsdale DR
J Invasive Cardiol; 2005 Jan; 17(1):13. PubMed ID: 15640532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
